| Novartis Pharma Schweiz AG - Simbrinza, Brinzolamid 10mg/ml, Brimonidintartrat 2mg/ml, Augentropfensuspension | | 65186 | | 01 | | Simbrinza, Brinzolamid 10mg/ml | | Brimonidintartrat 2mg/ml, Augentropfensuspension | | S01EC54 | | Brinzolamide, Combinations | | 13.01.2015 | | |
| | Composition | | brinzolamidum 10 mg, brimonidini tartras 2 mg, carbomerum 974P, natrii chloridum, mannitolum, propylenglycolum, tyloxapolum, acidum boricum, natrii hydroxidum aut acidum hydrochloridum ad pH, benzalkonii chloridum 0.03 mg, aqua purificata q.s. ad suspensionem pro 1 ml. | | Packungsbestandteile | | Brimonidintartrat | | | | | | | | Principe actif | Concentr. |
|---|
| Brimonidine Tartrate | 2 mg/ml | | Brinzolamide | 10 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Brimonidine Tartrate | 2 mg | | Brinzolamide | 10 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acide Borique | | | Aqua Purificata | | | Benzalkonium Chlorure | 0.03 mg/ml | | Carbomerum 974P | | | Mannitol | | | Sodium Chlorure | | | Natrii Hydroxidum aut Acidum Hydrochloridum ad Ph | | | Propylenglycol | | | Tyloxapolum | |
| |
| |
|
